PHARMACEUTICAL COMPOSITIONS FOR CARDIOPROTECTION
- 专利权人:
- 发明人:
- 申请号：
- EP14700845.2
- 公开号：
- EP2943212B1
- 申请日:
- 2014.01.14
- 申请国别(地区):
- EP
- 年份:
- 2018
- 代理人:
- 摘要：
- The present invention relates to methods and pharmaceutical compositions for cardioprotection of subjects who experienced a myocardial infarction. In particular, the present invention relates to a ligand of the sonic hedgehog signaling pathway for use in the cardioprotection of a subject who experienced a myocardial infarction.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- HIPPO PATHWAY DEFICIENCY REVERSES SYSTOLIC HEART FAILURE POST-INFARCTION
- HUMANIN COMPOSITIONS, METHODS AND USES FOR PROTECTING HEART FROM STRESS AND CHEMOTHERAPY
- METHOD AND SYSTEM FOR NEUROCARDIAC DIFFERENTIAL ANALYSIS OF ISCHEMIA AND MYOCARDIAL INFARCTION
- Procedure for preparation of endocrine gene 2 (EDG-2, EDG2) receptor inhibitors for treatment of cardiovascular diseases, myocardial failure, myocardial infarction, myocardial infarction, myocardial infarction modification Myocardium, vascular remodeling, myocardial hypersensitivity and hypertension.
- ПРИМЕНЕНИЕ ПЕПТИДА СЕМАКС (АКТГ4-7-Pro-Gly-Pro) ДЛЯ УЛУЧШЕНИЯ ТЕЧЕНИЯ РЕМОДЕЛИРОВАНИЯ МИОКАРДА ПОСЛЕ ИНФАРКТА
